|
|
| Product Name: | CEF19 | | Synonyms: | H-TYR-PRO-LEU-HIS-GLU-GLN-HIS-GLY-MET-OH;EPSTEIN-BARR VIRUS LATENT NA-3A (458-466);CEF19;YPLHEQHGM;CEF19, Epstein-Barr Virus latent NA-3A (458-466);L-Methionine, L-tyrosyl-L-prolyl-L-leucyl-L-histidyl-L-α-glutamyl-L-glutaminyl-L-histidylglycyl- | | CAS: | 157876-41-0 | | MF: | C49H70N14O14S | | MW: | 1111.23 | | EINECS: | | | Product Categories: | peptide | | Mol File: | Mol File |  |
| | CEF19 Chemical Properties |
| Boiling point | 1705.0±65.0 °C(Predicted) | | density | 1.389±0.06 g/cm3(Predicted) | | pka | 3.22±0.10(Predicted) | | Sequence | Tyr-Pro-Leu-His-Glu-Gln-His-Gly-Met |
| | CEF19 Usage And Synthesis |
| Uses | CEF19, Epstein-Barr Virus latent NA-3A (458-466) is a single peptide epitope, YPLHEQHGM, representing residues 458-466 of the type 1 Epstein-Barr Virus (EBV) nuclear antigen 3A protein (B95.8 strain). CEF19, Epstein-Barr Virus latent NA-3A (458-466) can significantly affect cytotoxic T-lymphocyte (CTL) recognition[1]. | | References | [1] Lee SP, et al. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population. Eur J Immunol. 1995 Jan;25(1):102-10. DOI:10.1002/eji.1830250119 |
| | CEF19 Preparation Products And Raw materials |
|